Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma

Technology appraisal guidance
Reference number: TA306
Published: 26 February 2014

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document

$Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document$

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2 document
31 December 2013
(417.01 Kb 1 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 20 December 2013